Tiziana Life Sciences PLC - London-based oncology and immunology treatments - Gregor MacRae steps down as director with immediate effect. Says looking for new non-executive director with Nasdaq audit committee experience.
Current stock price: 90.00 pence
Year-to-date change: up more than 100%, 41.00p on January 2
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.